Drug
Desmopressin acetate
Desmopressin acetate is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_3
1
20%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A2 (40.0%)
Trials by Status
completed240%
unknown240%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingnot_applicable
DDAVP for Pituitary Adenoma
NCT04569591
unknownphase_4
Adding Desmopressin to Tamsulosin for Treatment of BPH
NCT05945420
unknownphase_4
Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis
NCT04545931
completedphase_3
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
NCT00477490
completednot_applicable
Treatment and Management of Women With Bleeding Disorders
NCT00111215
Clinical Trials (5)
Showing 5 of 5 trials
NCT04569591Not Applicable
DDAVP for Pituitary Adenoma
NCT05945420Phase 4
Adding Desmopressin to Tamsulosin for Treatment of BPH
NCT04545931Phase 4
Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis
NCT00477490Phase 3
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
NCT00111215Not Applicable
Treatment and Management of Women With Bleeding Disorders
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5